Home > Financial Ratios > AARTI PHARMALABS

AARTI PHARMALABS
Core EBITDA Margin

    Back to All Ratios
COMMUNITY POLL
for AARTI PHARMALABS
Please provide your vote to see the results

AARTI PHARMALABS Last 5 Year Core EBITDA Margin History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
   Core EBITDA Margin(%) 21.9620.8417.5817.11-

What is the latest Core EBITDA Margin ratio of AARTI PHARMALABS ?

The latest Core EBITDA Margin ratio of AARTI PHARMALABS is 21.96 based on Mar2025 Consolidated results.
Year Core EBITDA Margin
Mar202521.96
Mar202420.84
Mar202317.58
Mar202217.11
Mar2021-

How is Core EBITDA Margin of AARTI PHARMALABS Trending?

Years Core EBITDA Margin % Change
Mar2025 21.96
5.37
Mar2024 20.84
18.54
Mar2023 17.58
2.75
Mar2022 17.11
0
Mar2021 0 -

Other Financial Ratios of AARTI PHARMALABS


Compare Core EBITDA Margin ratio of peers of AARTI PHARMALABS

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
AARTI PHARMALABS ₹7,539.7 Cr -0% -4.6% 39.4% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹407,791.0 Cr 1.2% 4.2% -10.9% Stock Analytics
DIVIS LABORATORIES ₹174,885.0 Cr -0.5% 8.9% 10.8% Stock Analytics
CIPLA ₹127,930.0 Cr 0.4% 3.7% 8% Stock Analytics
TORRENT PHARMACEUTICALS ₹121,108.0 Cr -0% -2.1% 6.6% Stock Analytics
DR REDDYS LABORATORIES ₹107,164.0 Cr 2.2% -1.8% -4.4% Stock Analytics


AARTI PHARMALABS Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
AARTI PHARMALABS

-0%

-4.6%

39.4%

SENSEX

0.9%

2.5%

3.7%


You may also like the below Video Courses